Tag: COVID-19

COVID-19

Washington Focus

Biden Gears Up After Win, Announces COVID-19 Advisory Board

Biden Gears Up After Win, Announces COVID-19 Advisory Board

Nov. 9, 2020 – Just two days after his election victory became apparent, President-elect Joe Biden signaled his number one priority by naming the co-chairs and membership of his COVID-19 Advisory Board. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science […]

Read more

Regulatory/FDA

Bad Ad Complaints Yield Two OPDP Warning Letters, One on COVID Email Claims

Bad Ad Complaints Yield Two OPDP Warning Letters, One on COVID Email Claims

Oct. 12, 2020 – The FDA’s Office of Prescription Drug Promotion (OPDP) enforcement efforts are picking up steam following a slow start – just one enforcement letter issued between January 2020 and July 2020 – with two recent Warning Letters resulting from complaints through the agency’s Bad Ad Program. In a Sept. 22 Warning Letter […]

Read more

Washington Focus

Political Pressure on Federal Health Agencies Is Eroding Public Trust

Political Pressure on Federal Health Agencies Is Eroding Public Trust

Sept. 14, 2020 – As the COVID-19 pandemic persists and the race for a vaccine to prevent contracting the virus heats up, there is a great deal of misinformation circulating about treatments and the majority of Americans are concerned that political pressure from the Trump administration will lead the Food and Drug Administration to approve […]

Read more

Regulatory/FDA

Despite COVID-19 Distractions, FDA Approving Drugs at Fast Pace

Despite COVID-19 Distractions, FDA Approving Drugs at Fast Pace

Aug. 20, 2020 – The Food and Drug Administration’s (FDA’s) ability to approve new drugs while juggling new responsibilities during the COVID-19 pandemic appears to be exceeding expectations, with the agency approving 36 novel drugs to date in 2020, an increase from the 24 new molecular entities (NMEs) approved by this date in 2019 (with […]

Read more

Washington Focus

Change in Hospital COVID-19 Case Reporting Raises Fear of Politicization of Data

Change in Hospital COVID-19 Case Reporting Raises Fear of Politicization of Data

July 20, 2020 – The Trump administration instructed hospital systems and providers last week that they should no longer report data on COVID-19 cases, hospitalizations, deaths, positive test results, etc. to the Centers for Disease Control and Prevention’s (CDC’s) National Healthcare Safety Network site, and instead should send this information to a newly launched data […]

Read more

Legislative

Pharma Reputation on the Line During COVID-19 Crisis

Pharma Reputation on the Line During COVID-19 Crisis

June 29, 2020 – After being scrutinized for years regarding drug pricing issues, the biopharma industry is enjoying a boost in public opinion during the COVID-19 crisis. However, that boost may slowly be fading as lawmakers and the public continue to be skeptical of the industry, as evidenced by two bills introduced in the House […]

Read more

Data Privacy

Pandemic Ups Need for Data Privacy Legislation, but 2020 Prospects Are Slim

Pandemic Ups Need for Data Privacy Legislation, but 2020 Prospects Are Slim

June 15, 2020 – The COVID-19 pandemic has brought increased use of telemedicine and group conferencing platforms, as well as prompted talk of using cellphones to do contact tracing, but this uptick in using technology in new and expanded ways also has increased the risks to personal data. Unfortunately, at a time when consumer data […]

Read more

Regulatory/FDA

Hahn: Lessons Learned in Pandemic May Lead to Permanent FDA Changes

Hahn: Lessons Learned in Pandemic May Lead to Permanent FDA Changes

June 9, 2020 – Speaking at a June 1 presentation to the Alliance for a Stronger FDA, FDA Commissioner Dr. Stephen Hahn said that despite criticisms of its performance during the COVID-19 pandemic, FDA’s “decisions [will] always be rooted in science,” and that lessons learned during the pandemic “will lead to permanent improvements at the […]

Read more

DTC Advertising

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

June 1, 2020 – Although the pharmaceutical industry’s reputation has taken a hit in recent years over drug-pricing concerns, the results of recent Harris Polls show that the industry’s role in helping to combat COVID-19 may be helping to rehabilitate its image. According to Harris Polls conducted between March 14 and May 17, 33 percent […]

Read more

Data Privacy

Hackers Are Targeting COVID-19 Healthcare Data

Hackers Are Targeting COVID-19 Healthcare Data

May 18, 2020 – A joint alert issued recently by the U.S. Cybersecurity and Infrastructure Security Agency (CISA) and the U.K. National Cyber Security Centre (NCSC) warns that they continue to see “indications that advanced persistent threat (APT) groups are exploiting the [COVID-19] pandemic” by targeting organizations involved in the COVID-19 response, including “healthcare bodies, […]

Read more